Ex vivo evidence suggests that cyclo-oxygenase ( COX ) 2-preferential inhibitor nonsteroidal anti-inflammatory drugs ( NSAIDs ) , such as meloxicam , have a less detrimental effect on intestinal healing than flunixin meglumine ( FM ) .